Hims stock popped Monday after the FDA reportedly said it would reconsider its decision to bar compounders from selling knockoff tirzepatide.

The UK Government has signed a collaboration agreement with Lilly, the pharmaceutical giant behind weight loss medication ...

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

Diet and exercise have always proven effective for weight loss, but some supplements can help speed the process. We think ...

Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) ...

My own experience initially led me to believe that weight loss was just a matter of commitment and a modicum of self-control.

PS makes wellness more accessible through real-life stories, first-person perspectives, and expert-backed information. Our ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The prescription drug has been all over the news in the past couple of years - but the name Ozempic has become something of a ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...